A US Navy veteran who one day began having severe chest and back pain was diagnosed with stage 2 pancreatic cancer—one of the deadliest. According to doctors, the symptoms she had were completely ...
FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope ...
Pancreatic cancer is a notoriously high mortality cancer. Even in the latest data, 2022 cancer survival statistics, the ...
Merck (NYSE:MRK) said a Phase 3 study of its drug Keytruda in the treatment of a certain type of ovarian cancer met its ...
Get the facts about biopsies and cancer spread. Learn about the low risk of tumor seeding and the crucial role of biopsies in cancer diagnosis.
The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...
Intech Investment Management LLC purchased a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) in the third quarter, HoldingsChannel.com reports. The institutional ...
Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. | Profound Medical CEO Arun Menawat discusses TULSA-PRO, an innovative technology for treating ...
Stable disease (SD) at four months post-initiation of dosing was seen in 10 of 21 (48%) evaluable monotherapy patients, and importantly included one patient dosed at the MTD who had a partial response ...
Enanta's oral N-protein inhibitor zelicapavir showed positive Phase 2 results in pediatric RSV. Carisma Therapeutics announces 34% workforce reduction. Innovent Biologics reports promising data for ...
Research and development (R&D) activities are anticipated to drive growth in the adenosine antagonists market by identifying novel therapeutic applications, such as in neurodegenerative diseases, ...